BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 29/09/2023

FDA Announces Fee Rate for Using Priority Review Voucher in FY 2024

The US Food and Drug Administration (FDA) has announced the fee rate for using a priority review voucher for fiscal year 2024, which is based on the average cost incurred by the agency to review priority review applications versus non-priority review applications in the previous fiscal year.

Source: Federal Register — Food and Drug AdministrationOpen original release →